171 related articles for article (PubMed ID: 37899785)
21. ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer.
Liu X; Qin J; Nie J; Gao R; Hu S; Sun H; Wang S; Pan Y
Front Immunol; 2023; 14():1185208. PubMed ID: 37691929
[TBL] [Abstract][Full Text] [Related]
22. Efficient expansion of mouse hematopoietic stem cells ex vivo by membrane anchored Angptl2.
Yang J; Shen G; Cao J; Zhang J; Gu Y; Zhang X; Jiang X; Luo M; Lu Z
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 1):42-47. PubMed ID: 35675737
[TBL] [Abstract][Full Text] [Related]
23. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
25. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
[TBL] [Abstract][Full Text] [Related]
26. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
27. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
28. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
29. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
[TBL] [Abstract][Full Text] [Related]
30. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
33. Serum Angiopoietin-like Protein 2 Improves Preoperative Detection of Lymph Node Metastasis in Colorectal Cancer.
Toiyama Y; Inoue Y; Shimura T; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Araki T; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2015 May; 35(5):2849-56. PubMed ID: 25964566
[TBL] [Abstract][Full Text] [Related]
34. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
Grotowski M; Maruszyński M; Piechota W
Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin-like protein 2 as a potential biomarker for colorectal cancer.
Yoshinaga T; Shigemitsu T; Nishimata H; Kitazono M; Hori E; Tomiyoshi A; Takei T; Yoshida M
Mol Clin Oncol; 2015 Sep; 3(5):1080-1084. PubMed ID: 26623054
[TBL] [Abstract][Full Text] [Related]
36. Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers.
Wang CX; Zhuang HB; Shi ZS; Qiu CZ; Chen ZX; Tang LF
Dis Markers; 2021; 2021():8880282. PubMed ID: 33680216
[TBL] [Abstract][Full Text] [Related]
37. Free Fatty Acid is a Promising Biomarker in Triage Screening for Patients with Colorectal Cancer: A Case-Control Study.
Zhu B; Zhang J; Zheng Q; Dong B; Wang M; Liu J; Cao Y
Cancer Manag Res; 2021; 13():3749-3759. PubMed ID: 34007210
[TBL] [Abstract][Full Text] [Related]
38. An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.
Carbone C; Piro G; Fassan M; Tamburrino A; Mina MM; Zanotto M; Chiao PJ; Bassi C; Scarpa A; Tortora G; Melisi D
Oncotarget; 2015 May; 6(15):13822-34. PubMed ID: 25360865
[TBL] [Abstract][Full Text] [Related]
39. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.
Meng W; Zhu HH; Xu ZF; Cai SR; Dong Q; Pan QR; Zheng S; Zhang SZ
World J Gastrointest Oncol; 2012 Jun; 4(6):145-51. PubMed ID: 22737276
[TBL] [Abstract][Full Text] [Related]
40. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
